maytansine has been researched along with Hemostatic-Disorders* in 1 studies
1 other study(ies) available for maytansine and Hemostatic-Disorders
| Article | Year |
|---|---|
First case of trastuzumab emtansine-associated hemorrhagic telangiectasias treated with propranolol.
Topics: Ado-Trastuzumab Emtansine; Adrenergic beta-Antagonists; Antineoplastic Agents, Immunological; Female; Hemostatic Disorders; Humans; Maytansine; Middle Aged; Propranolol; Skin; Telangiectasis; Trastuzumab; Treatment Outcome | 2019 |